Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin; Melissa M Higdon; Laith J Abu Raddad; Nick Andrews; Rafael Araos; Yair Goldberg; Michelle J Groome; Amit Huppert; Katherine L O'Brien; Peter G. Smith; Annelies Wilder-Smith; Scott Zeger; Maria Deloria Knoll; Minal K Patel

doi:10.1016/s0140-6736(22)00152-0

Abstract

Coalition for Epidemic Preparedness Innovations.

Related Publications

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra López‐León , Talía Wegman-Ostrosky , Carol Perelman +4 more

Abstract COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systematic review and meta-analysis a...

2021 Scientific Reports 2368 citations

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey , Sue Ann Costa Clemens , Shabir A. Madhi +97 more

UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, ...

2020 The Lancet 4945 citations

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal , Nick Andrews , Charlotte Gower +12 more

Abstract Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (includ...

2021 BMJ 1367 citations

SARS-CoV-2 vaccines in development

Florian Krammer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti , Katie Ewer , Parvinder K. Aley +97 more

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a v...

2020 The Lancet 2590 citations

Publication Info

Year: 2022
Type: article
Volume: 399
Issue: 10328
Pages: 924-944
Citations: 1146
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1146

OpenAlex

Cite This

APA Style

                            
                                
                                    Daniel R. Feikin, 
                                
                                    Melissa M Higdon, 
                                
                                    Laith J Abu Raddad
                                
                                et al.
                            
                            (2022). 
                            Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. 
                            The Lancet
                            , 399
                            (10328)
                            , 924-944.
                            https://doi.org/10.1016/s0140-6736(22)00152-0
                        

Identifiers

DOI: 10.1016/s0140-6736(22)00152-0